Credit: Shutterstock/Kathy Wong for Endpoints News
Foreign investors fled Chinese biotech after the pandemic. They still haven’t come back
Outside biotech money isn’t pouring into China like it used to.
In 2020 and 2021, venture investors put nearly $8 billion into Chinese biopharmas. But …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
